1. Home
  2. NCL vs VTAK Comparison

NCL vs VTAK Comparison

Compare NCL & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northann Corp.

NCL

Northann Corp.

HOLD

Current Price

$0.15

Market Cap

3.6M

Sector

N/A

ML Signal

HOLD

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$1.22

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCL
VTAK
Founded
2013
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
2.9M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
NCL
VTAK
Price
$0.15
$1.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
162.5K
733.1K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
51.43
89.53
EPS
N/A
N/A
Revenue
$15,349,854.00
$442,000.00
Revenue This Year
N/A
$822.86
Revenue Next Year
N/A
$168.42
P/E Ratio
N/A
N/A
Revenue Growth
9.86
3057.14
52 Week Low
$0.10
$0.15
52 Week High
$1.47
$4.31

Technical Indicators

Market Signals
Indicator
NCL
VTAK
Relative Strength Index (RSI) 43.11 36.32
Support Level $0.14 $1.14
Resistance Level $0.16 $2.08
Average True Range (ATR) 0.01 0.14
MACD 0.00 -0.01
Stochastic Oscillator 36.40 1.60

Price Performance

Historical Comparison
NCL
VTAK

About NCL Northann Corp.

Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. It offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, mainly through its sales network in North America and Europe.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: